On the one hand, CS can inhibit the synthesis of the pro-inflammatory enzyme COX-2, leading to the down-regulation of the anti-apoptotic protein BCL-XL, thereby increasing the sensitivity of tumor cells to chemotherapeutics. Here, BCL2L1 is linked to neoplasm.